Autism and Private Equity: A Cautionary Tale
What does the bankruptcy of CARD, the largest autism treatment company in the U.S., have to teach us about the role of private equity in health care?
Does Applied Behavior Analysis Really Help People with Autism?
The leading U.S. therapy for autism is no panacea and has shown mixed results. Critics say it’s time to look for alternatives—and consult people with autism.
Can Psychedelics Slow Dementia?
The link between dementia and neuroplasticity inspires researchers to test psychedelics as a potential treatment for cognitive impairment.
Why do so many people in industrialized Western societies have unhealthy microbiomes that lack diversity?
The Urgent Problem of Regulating AI in Medicine
How should medical AI be regulated, and who is responsible when deadly mistakes occur?
No Catastrophe Too Small
The emerging field of disaster microbiology builds on the fact that human health is inherently interconnected with animals, plants, microbes, and the environment—for better or worse.
Renee Wegrzyn Plans to Level Up U.S. Health with ARPA-H
As head of the government’s new federal agency, she’s attacking a wide range of problems from the molecular to the societal.
Let’s Eradicate Polio This Winter
It feels like we’ve been here before. Here’s why it’s different this time.
Breathwork Is Booming
As more people seek help for their mental health, simple techniques that link mind and body are powerful alternatives to traditional talk therapy.